πŸ‡ΊπŸ‡Έ FDA
Patent

US 7192940

Ether compounds

granted A61PA61P1/18A61P13/12

Quick answer

US patent 7192940 (Ether compounds) held by Esperion Therapeutics, Inc. expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28